Healthcare.gov sets enrollment record despite repeal threat

400,000 more people bought health plans through the Affordable Care Act’s insurance marketplace in 2016 than 2015, according to the final open enrollment figures released by HHS for coverage beginning Jan. 1, 2017.

Through the extended marketplace deadline of Dec. 19, a record 6.4 million people selected a health plan. 2 million of them were new customers. More than 4.3 million returning customers either picked a new plan or “actively” renewed it, while those whose coverage automatically renewed aren’t included in the figures.

“With a record 6.4 million consumers selecting plans for January 1, Americans are once again proving that Marketplace coverage is vital to them and their families,” said HHS Secretary Sylvia Burwell.  “Now, we want uninsured Americans who have not yet signed up to know they have not missed their chance to get covered. Open Enrollment for 2017 continues through January 31st.”

Enrollment had initially spiked after the unexpected presidential election victory of Donald Trump, who has promised to repeal the ACA. As in past open enrollment periods, sign-ups rose sharply as the deadline for Jan. 1 coverage approached. Dec. 15, the original deadline day, was the biggest single enrollment day ever, with 670,000 people selecting a plan, beating the previous record of 600,000 set on the same day in 2015.

The figures only cover customers in states which rely on the federal Healthcare.gov site, not those in states with their own exchanges. The record enrollment is in spite of the highest year-to-year premium increase in the marketplace’s short history, with benchmark premiums on the federally-facilitated marketplace going up by an average of 25 percent.

Before open enrollment began, HHS had projected 13.8 million people would buy insurance plans off the exchanges for 2017. Customers can still do so through Jan. 31, with coverage beginning on either Feb. 1 or March 1.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.